




Searching News Database: Traumatic Brain Injury
HSMN NewsFeed - 18 Nov 2022
Synaptogenix Announces $15 Million Private Placement with Existing Investors
Synaptogenix Announces $15 Million Private Placement with Existing Investors
HSMN NewsFeed - 18 Oct 2021
NeuExcell Therapeutics names Lori Gavrin as Chief Business and Strategy Officer
NeuExcell Therapeutics names Lori Gavrin as Chief Business and Strategy Officer
HSMN NewsFeed - 14 Sep 2021
Jupiter Orphan Therapeutics, Inc. Announces New Corporate Name, Jupiter Neurosciences, Inc.
Jupiter Orphan Therapeutics, Inc. Announces New Corporate Name, Jupiter Neurosciences, Inc.
HSMN NewsFeed - 30 Aug 2021
NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth
NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth
HSMN NewsFeed - 19 Aug 2021
Stryker Heads To Truist Field To Educate Charlotte Knights Fans On Mako SmartRobotics(TM) Technology
Stryker Heads To Truist Field To Educate Charlotte Knights Fans On Mako SmartRobotics(TM) Technology
HSMN NewsFeed - 3 Jun 2021
vasopharm GmbH Announces Results of the NOSTRA III Traumatic Brain Injury Phase III Study
vasopharm GmbH Announces Results of the NOSTRA III Traumatic Brain Injury Phase III Study
HSMN NewsFeed - 11 Aug 2020
IRRAS Announces First Global Patient Treatment with Newly Developed Hummingbird Solo ICP Monitoring System
IRRAS Announces First Global Patient Treatment with Newly Developed Hummingbird Solo ICP Monitoring System
HSMN NewsFeed - 29 Jan 2020
vasopharm Completes Patient Enrollment for Phase III Traumatic Brain Injury Trial (NOSTRA)
vasopharm Completes Patient Enrollment for Phase III Traumatic Brain Injury Trial (NOSTRA)
HSMN NewsFeed - 9 Jan 2020
BioDirection(R), Inc. Appoints Dr. Jean-Luc Boulnois to its Board of Directors
BioDirection(R), Inc. Appoints Dr. Jean-Luc Boulnois to its Board of Directors
HSMN NewsFeed - 18 Dec 2019
NeuroTrauma Sciences Appoints Dr. Todd Verdoorn as Vice President of Research and Development
NeuroTrauma Sciences Appoints Dr. Todd Verdoorn as Vice President of Research and Development
HSMN NewsFeed - 28 Aug 2019
Harmonic Bionics Announces Appointment of Christopher Prentice as Chief Executive Officer
Harmonic Bionics Announces Appointment of Christopher Prentice as Chief Executive Officer
HSMN NewsFeed - 21 Jun 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
HSMN NewsFeed - 11 Feb 2019
BioDirection Receives Breakthrough Device Designation from FDA for Tbit(TM) System
BioDirection Receives Breakthrough Device Designation from FDA for Tbit(TM) System
HSMN NewsFeed - 11 Dec 2018
Avanir Pharmaceuticals Announces Termination of License Agreement with Optinose for ONZETRA(R) Xsail(R)
Avanir Pharmaceuticals Announces Termination of License Agreement with Optinose for ONZETRA(R) Xsail(R)
HSMN NewsFeed - 23 Aug 2018
BioDirection, Inc. Announces Exclusive Worldwide License for Tbit(TM) System to Diagnose and Monitor Sepsis
BioDirection, Inc. Announces Exclusive Worldwide License for Tbit(TM) System to Diagnose and Monitor Sepsis
HSMN NewsFeed - 1 Jun 2018
Fortuna Fix Announces Appointment of Madhavan Balachandran to Board of Directors
Fortuna Fix Announces Appointment of Madhavan Balachandran to Board of Directors
HSMN NewsFeed - 14 Feb 2018
SanBio and Teijin to Terminate Licensing Agreement regarding SB623 for Stroke Treatment
SanBio and Teijin to Terminate Licensing Agreement regarding SB623 for Stroke Treatment
HSMN NewsFeed - 2 Nov 2017
Therapix Biosciences' Board Chairman, Ascher Shmulewitz, Appointed as Interim Chief Executive Officer
Therapix Biosciences' Board Chairman, Ascher Shmulewitz, Appointed as Interim Chief Executive Officer
HSMN NewsFeed - 20 Apr 2017
Arkis BioSciences Expands Clinical Use Of Its New Minimally Invasive Tunneling Guidewire(TM) Technology
Arkis BioSciences Expands Clinical Use Of Its New Minimally Invasive Tunneling Guidewire(TM) Technology
HSMN NewsFeed - 13 Oct 2016
NeuroVive discontinues development of CicloMulsion for acute kidney injury
NeuroVive discontinues development of CicloMulsion for acute kidney injury
HSMN NewsFeed - 22 Jan 2016
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
HSMN NewsFeed - 21 Jan 2016
vasopharm Announces EUR 20 Million Fundraising to Progress Treatment for Traumatic Brain Injury
vasopharm Announces EUR 20 Million Fundraising to Progress Treatment for Traumatic Brain Injury
HSMN NewsFeed - 17 Feb 2014
Neurovive Pharmaceutical: NeuroVive Treats Final Patient in European Phase III Trial on CicloMulsion(R)
Neurovive Pharmaceutical: NeuroVive Treats Final Patient in European Phase III Trial on CicloMulsion(R)
HSMN NewsFeed - 16 Dec 2013
Premier Biomedical Secures $5 Million Equity Funding From Kodiak Capital Group, LLC
Premier Biomedical Secures $5 Million Equity Funding From Kodiak Capital Group, LLC
HSMN NewsFeed - 21 Oct 2013
Integra LifeSciences Introduces Next-Generation Licox(R) Brain Tissue Oxygen Monitoring System
Integra LifeSciences Introduces Next-Generation Licox(R) Brain Tissue Oxygen Monitoring System
HSMN NewsFeed - 18 Jun 2013
NeurOptics Appoints Neurocritical Care Industry Veteran William Worthen as President
NeurOptics Appoints Neurocritical Care Industry Veteran William Worthen as President
HSMN NewsFeed - 13 Mar 2013
Hospital Acceptance of Vycor's Patented VBAS Minimally Invasive Neurosurgical Device Continues to Accelerate
Hospital Acceptance of Vycor's Patented VBAS Minimally Invasive Neurosurgical Device Continues to Accelerate
HSMN NewsFeed - 16 Jan 2013
InfraScan Receives FDA Approval of Next Generation, Noninvasive Handheld Brain Hematoma Detector
InfraScan Receives FDA Approval of Next Generation, Noninvasive Handheld Brain Hematoma Detector
HSMN NewsFeed - 23 Jul 2012
InnerSpace Neuro Announces Launch of New, Tunneled TBI Catheter, Abstract Presentation
InnerSpace Neuro Announces Launch of New, Tunneled TBI Catheter, Abstract Presentation
HSMN NewsFeed - 14 May 2012
Bioness Announces FDA Clearance of Smaller Leg Cuff for Use with Its L300 Foot Drop System
Bioness Announces FDA Clearance of Smaller Leg Cuff for Use with Its L300 Foot Drop System
HSMN NewsFeed - 16 Feb 2012
Mnemosyne Pharmaceuticals, Inc. Completes $5.4 Million Series A Round to Support Drug Discovery Programs
Mnemosyne Pharmaceuticals, Inc. Completes $5.4 Million Series A Round to Support Drug Discovery Programs
HSMN NewsFeed - 15 Feb 2012
Researchers Show TB4 Provides Both Neuroprotection and Neurorestoration after Traumatic Brain Injury
Researchers Show TB4 Provides Both Neuroprotection and Neurorestoration after Traumatic Brain Injury
HSMN NewsFeed - 30 Nov 2011
SAGE Therapeutics Appoints Chief Scientific Officer, Strengthens Management Team
SAGE Therapeutics Appoints Chief Scientific Officer, Strengthens Management Team
HSMN NewsFeed - 9 Feb 2011
Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
HSMN NewsFeed - 31 Jan 2011
AVANIR Pharmaceuticals Announces U.S. Launch and Availability of NUEDEXTA for Pseudobulbar Affect
AVANIR Pharmaceuticals Announces U.S. Launch and Availability of NUEDEXTA for Pseudobulbar Affect
HSMN NewsFeed - 27 Jan 2011
BrainScope(R) Announces Multi-Center Clinical Study of Head Injury in the United Kingdom
BrainScope(R) Announces Multi-Center Clinical Study of Head Injury in the United Kingdom
HSMN NewsFeed - 25 Aug 2010
Neuralstem Files FDA Application for First Chronic Spinal Cord Injury Stem Cell Trial
Neuralstem Files FDA Application for First Chronic Spinal Cord Injury Stem Cell Trial
HSMN NewsFeed - 19 Jul 2010
NovaVision's FDA-Cleared Visual Restoration Therapy (VRT) System and Company Assets Now Available
NovaVision's FDA-Cleared Visual Restoration Therapy (VRT) System and Company Assets Now Available
HSMN NewsFeed - 22 Jun 2010
InnerSpace Announces U.S. Market Launch of Hummingbird Neuromonitoring Line
InnerSpace Announces U.S. Market Launch of Hummingbird Neuromonitoring Line
HSMN NewsFeed - 29 Mar 2010
Oxygen Biotherapeutics Now Marketing New Formulation of Dermacyte(TM) Oxygen Concentrate
Oxygen Biotherapeutics Now Marketing New Formulation of Dermacyte(TM) Oxygen Concentrate
HSMN NewsFeed - 22 Feb 2010
Acorda Therapeutics Announces Adrian L. Rabinowicz Joins as Senior Vice President of Medical Affairs
Acorda Therapeutics Announces Adrian L. Rabinowicz Joins as Senior Vice President of Medical Affairs
HSMN NewsFeed - 10 Sep 2009
Neuro Kinetics at Battlefield Healthcare Conference: 'Promising' Technology Can Aid Brain-Injured Soldiers
Neuro Kinetics at Battlefield Healthcare Conference: 'Promising' Technology Can Aid Brain-Injured Soldiers
HSMN NewsFeed - 14 Aug 2009
Oxygen Biotherapeutics, Inc. to Begin Oxycyte(R) Phase II Clinical Trials in Switzerland
Oxygen Biotherapeutics, Inc. to Begin Oxycyte(R) Phase II Clinical Trials in Switzerland
HSMN NewsFeed - 23 Apr 2009
Banyan Biomarkers, Inc. Targets Protein Biomarkers to Detect Mild to Moderate Traumatic Brain Injury
Banyan Biomarkers, Inc. Targets Protein Biomarkers to Detect Mild to Moderate Traumatic Brain Injury
HSMN NewsFeed - 17 Apr 2009
Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to the Mind Research Network
Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to the Mind Research Network
HSMN NewsFeed - 17 Mar 2009
Oxygen Biotherapeutics, Inc. to Launch Product Line of Oxycyte(R) Gels for the Over-the-Counter Market
Oxygen Biotherapeutics, Inc. to Launch Product Line of Oxycyte(R) Gels for the Over-the-Counter Market
HSMN NewsFeed - 27 Jan 2009
Oxygen Biotherapeutics, Inc. Submits Request for Designation to FDA for Oxycyte(R)-based Wound Care Product
Oxygen Biotherapeutics, Inc. Submits Request for Designation to FDA for Oxycyte(R)-based Wound Care Product
HSMN NewsFeed - 12 Sep 2008
Oxygen Biotherapeutics, Inc. Names Robert F. Diegelmann to Lead New Wound Care Division
Oxygen Biotherapeutics, Inc. Names Robert F. Diegelmann to Lead New Wound Care Division
HSMN NewsFeed - 9 Sep 2008
FDA Approves Testing to Explore Effectiveness of Rapid Patient Cooling in Traumatic Brain Injury Cases
FDA Approves Testing to Explore Effectiveness of Rapid Patient Cooling in Traumatic Brain Injury Cases
HSMN NewsFeed - 12 Aug 2008
Oxygen Biotherapeutics Develops Gel Version of Oxycyte(R) for Treating Surface Wounds
Oxygen Biotherapeutics Develops Gel Version of Oxycyte(R) for Treating Surface Wounds
HSMN NewsFeed - 1 Jul 2008
Synthetic Blood International Changes Name to Oxygen Biotherapeutics, Inc.
Synthetic Blood International Changes Name to Oxygen Biotherapeutics, Inc.
HSMN NewsFeed - 24 Jun 2008
Novel Progesterone Formulation for Stroke and Traumatic Brain Injury Developed by Encore Therapeutics, Inc.
Novel Progesterone Formulation for Stroke and Traumatic Brain Injury Developed by Encore Therapeutics, Inc.
HSMN NewsFeed - 16 Jun 2008
NovaVision Appoints Medical Technology Veteran Rudy Mazzocchi as Chief Executive Officer
NovaVision Appoints Medical Technology Veteran Rudy Mazzocchi as Chief Executive Officer
HSMN NewsFeed - 23 Apr 2008
Stem Cell Therapeutics Corp. Receives "May Proceed" From FDA for Its Phase IIb Clinical Stroke Trial and IND
Stem Cell Therapeutics Corp. Receives "May Proceed" From FDA for Its Phase IIb Clinical Stroke Trial and IND
HSMN NewsFeed - 22 Apr 2008
Synthetic Blood International, Inc. to Seek Shareholder Approval for Name Change
Synthetic Blood International, Inc. to Seek Shareholder Approval for Name Change
HSMN NewsFeed - 31 Mar 2008
Synthetic Blood International, Inc. Announces New Leadership Roles to Continue Product Development Strategy
Synthetic Blood International, Inc. Announces New Leadership Roles to Continue Product Development Strategy
HSMN NewsFeed - 24 Mar 2008
Synthetic Blood International, Inc. Announces Passing of Interim CEO Robert Larsen
Synthetic Blood International, Inc. Announces Passing of Interim CEO Robert Larsen
HSMN NewsFeed - 26 Feb 2008
Synthetic Blood Announces Department of Defense Grant for Traumatic Brain Injury Clinical Trial with Oxycyte
Synthetic Blood Announces Department of Defense Grant for Traumatic Brain Injury Clinical Trial with Oxycyte
HSMN NewsFeed - 8 Feb 2008
Synthetic Blood Announces Medical Advisory Board Meeting Results, New Additions to Board
Synthetic Blood Announces Medical Advisory Board Meeting Results, New Additions to Board
HSMN NewsFeed - 11 Dec 2007
Synthetic Blood Announces Progress with Oxycyte Program in Traumatic Brain Injury
Synthetic Blood Announces Progress with Oxycyte Program in Traumatic Brain Injury
HSMN NewsFeed - 31 Jul 2007
Neuren to Obtain Late Stage Compound Through Hamilton Pharmaceuticals Acquisition
Neuren to Obtain Late Stage Compound Through Hamilton Pharmaceuticals Acquisition
HSMN NewsFeed - 11 Jun 2007
Intelect Medical Announces $7 Million Series B Investment from Boston Scientific and Greatbatch
Intelect Medical Announces $7 Million Series B Investment from Boston Scientific and Greatbatch
HSMN NewsFeed - 21 May 2007
Siemens Demonstrates World's First System Capable of Simultaneous Imaging of the Brain by MRI and PET
Siemens Demonstrates World's First System Capable of Simultaneous Imaging of the Brain by MRI and PET
HSMN NewsFeed - 15 Mar 2007
Alexian Brothers Hospital Network To Bring Advanced Brain Mapping Technology To Chicagoland
Alexian Brothers Hospital Network To Bring Advanced Brain Mapping Technology To Chicagoland
HSMN NewsFeed - 13 Mar 2007
Xytis Enrolls First Patient in Phase II Clinical Study With Anatibant (XY2405) for Traumatic Brain Injury
Xytis Enrolls First Patient in Phase II Clinical Study With Anatibant (XY2405) for Traumatic Brain Injury
HSMN NewsFeed - 9 Jan 2007
Xytis Begins Phase II Clinical Study with Anatibant (XY2405) for Traumatic Brain Injury
Xytis Begins Phase II Clinical Study with Anatibant (XY2405) for Traumatic Brain Injury
HSMN NewsFeed - 5 Jan 2007
Xytis Pharmaceuticals Names Dr. Vincent F. Simmon President, Chief Executive Officer and Director
Xytis Pharmaceuticals Names Dr. Vincent F. Simmon President, Chief Executive Officer and Director
HSMN NewsFeed - 22 Dec 2006
Synthetic Blood Reports Positive Preliminary Results From Traumatic Brain Injury Clinical Trial
Synthetic Blood Reports Positive Preliminary Results From Traumatic Brain Injury Clinical Trial
HSMN NewsFeed - 4 Dec 2006
New Atlanta-Based Pharmaceutical Company Focuses on Central Nervous System
New Atlanta-Based Pharmaceutical Company Focuses on Central Nervous System
HSMN NewsFeed - 9 Oct 2006
Integra LifeSciences Announces Launch of the Mobius(TM) Multi Modality Monitoring System
Integra LifeSciences Announces Launch of the Mobius(TM) Multi Modality Monitoring System
Additional items found! 60

Members Archive contains
60 additional stories matching:
Traumatic Brain Injury
(Password required)
Traumatic Brain Injury
(Password required)